149 related articles for article (PubMed ID: 20591632)
21. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
22. [Brain metastases of bronchial and breast carcinoma. Differences in metastatic behavior and prognosis].
Nieder C; Niewald M; Hagen T
Radiologe; 1995 Nov; 35(11):816-21. PubMed ID: 8657883
[TBL] [Abstract][Full Text] [Related]
23. CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer.
Lester JF; Macbeth FR; Brewster AE; Court JB; Iqbal N
Lung Cancer; 2004 Aug; 45(2):237-42. PubMed ID: 15246196
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
25. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
26. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
[TBL] [Abstract][Full Text] [Related]
27. Results of hypofractionated whole brain radiotherapy (2×8 Gy) for patients with brain metastases from lung cancer.
Ozkok S; Bolukbasi Y; Akay Akcay C; Yalman D
J BUON; 2011; 16(2):233-40. PubMed ID: 21766491
[TBL] [Abstract][Full Text] [Related]
28. [Surgery in non-small cell lung cancer of the superior sulcus: results of a combined preoperative and postoperative irradiation regime].
Pfannschmidt J; Muley T; Hoffmann H; Dienemann H
Zentralbl Chir; 2004 Aug; 129(4):270-5. PubMed ID: 15354247
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
30. Stereotactic radiotherapy for patients who initially presented with brain metastases from non-small cell carcinoma.
Nakayama H; Tokuuye K; Komatsu Y; Ishikawa H; Shiotani S; Nakada Y; Akine Y
Acta Oncol; 2004; 43(8):736-9. PubMed ID: 15764218
[TBL] [Abstract][Full Text] [Related]
31. Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective study.
Kim JH; Kim HS; Kwon JH; Park S; Kim HY; Jung JY; Kim HJ; Song HH; Lee GW; Lee SI; Gong SJ; Lee JA; Kim KJ; Zang DY
Lung Cancer; 2009 Mar; 63(3):405-9. PubMed ID: 18621432
[TBL] [Abstract][Full Text] [Related]
32. The elderly with synchronous non-small cell lung cancer and solitary brain metastasis: does palliative thoracic radiotherapy have a useful role?
Ampil F; Caldito G; Milligan S; Mills G; Nanda A
Lung Cancer; 2007 Jul; 57(1):60-5. PubMed ID: 17368627
[TBL] [Abstract][Full Text] [Related]
33. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
34. Prolonged survival after resection and radiotherapy for solitary brain metastases from non-small-cell lung cancer.
Chee R; Bydder S; Cameron F
Australas Radiol; 2007 Apr; 51(2):186-9. PubMed ID: 17419869
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of patients with non-small cell lung cancer with isolated brain metastases undergoing combined surgical treatment.
Getman V; Devyatko E; Dunkler D; Eckersberger F; End A; Klepetko W; Marta G; Mueller MR
Eur J Cardiothorac Surg; 2004 Jun; 25(6):1107-13. PubMed ID: 15145017
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer.
Yano T; Haro A; Yoshida T; Morodomi Y; Ito K; Shikada Y; Shoji F; Maruyama R; Maehara Y
J Surg Oncol; 2010 Dec; 102(7):852-5. PubMed ID: 20886558
[TBL] [Abstract][Full Text] [Related]
37. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
38. Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy.
Zabel A; Debus J
Lung Cancer; 2004 Aug; 45 Suppl 2():S247-52. PubMed ID: 15552806
[TBL] [Abstract][Full Text] [Related]
39. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Liao Z; Komaki R; Milas L; Yuan C; Kies M; Chang JY; Jeter M; Guerrero T; Blumenschien G; Smith CM; Fossella F; Brown B; Cox JD
Clin Cancer Res; 2005 May; 11(9):3342-8. PubMed ID: 15867233
[TBL] [Abstract][Full Text] [Related]
40. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.
Fang LC; Komaki R; Allen P; Guerrero T; Mohan R; Cox JD
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):108-16. PubMed ID: 16904517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
